Global Malaria Diagnostics Market Trends, Company Profiles, Analysis, Opportunities, Segmentation and Forecast, 2012 - 2020

1
Global Malaria Diagnostics Market (Technique and
Geography) - Size, Share, Global Trends, Company
Profiles, Demand, Insights, Analysis, Research,
Report, Opportunities, Segmentation and Forecast,
2012 - 2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
2
Report Overview
Global Malaria Diagnostics Market 2012 2020,
Size, Share, Trends, Company Profiles, Demand,
Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast by
Research Beam Malaria is caused by the
Plasmodium parasites and is transmitted by the
female anopheles mosquito. Diagnosis of malaria
includes detection by microscopy and blood tests.
According to the WHO, in 2012, there were an
estimated 203 million cases of malaria, which
resulted in an estimated 627,000 deaths. Accurate
and early diagnosis of malaria is important as
the patients recover rapidly if treatment is
started early and this has spurred investments in
diagnostic techniques. This has led to
technological advancements in development of
rapid diagnostic tests and is the major driver
for growth of this market. The challenges faced
by this market are in accelerating the acceptance
of diagnostic tests and their use in diagnosis of
malaria.
3
Report Overview
Malaria Diagnostics Market by Technique Diagnosis
of malaria is by use of Rapid Diagnostic Tests
(RDTs), Molecular diagnostics and detection of
parasites by microscopy. Malaria RDTs have
revolutionized diagnosis of malaria and are in
high demand. The tests are rapid with results
available in 15- 30 minutes. The tests detect the
presence of antigens of the malaria parasites.
Different types of RDTs are available for
diagnosis, some detecting single species of
plasmodium, while others are able to detect
multiple species. Competitive Analysis The
companies in this market include Beckman Coulter,
bioMerieux, Bio-Rad Laboratories, Novartis
Diagnostics, Seimens Healthcare, Ortho- Clinical
Diagnostics and others. In April 2013, Lumora, a
Molecular Diagnostic company, announced a
partnership with Foundation for Innovative New
Diagnostics (FIND) for developing a rapid, high
throughput malaria diagnostic assay that would
allow screening on a large scale.
4
Key Benefits

• In depth analysis of various geographic segments
  would help companies make strategic plans for
  each region
• Competitive analysis of key players helps in
  understanding the business strategies implemented
  by them
• Porters five forces model and SWOT analysis
  would enable stakeholders to make strategic
  decisions for business development
• Market estimations of the malaria diagnostic
  market are given, which would help in making
  development plans
• Enquire about an report _at_ http//www.researchbeam
  .com/malaria-diagnostics-market/enquire-about-repo
  rt

5
(No Transcript)